Online Only Articles

APOL1, α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia

Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA;Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, IL, USA
Department of Public Health Sciences, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Illinois at Chicago, IL, USA
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Illinois at Chicago, IL, USA
Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
Department of Public Health Sciences, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Illinois at Chicago, IL, USA
Division of Nephrology, Department of Medicine, University of Illinois at Chicago, IL, USA
Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
Vol. 102 No. 1 (2017): January, 2017 https://doi.org/10.3324/haematol.2016.154153